Urinalysis Marketย Worthย $6.8 billion by 2029 ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ:https://lnkd.in/dDHvbE5v The size of global urinalysis market in terms of revenue was estimated to be worth $4.3 billion in 2024 and is poised to reach $6.8 billion by 2029, growing at a CAGR of 9.6% from 2024 to 2029 The urinalysis market is set for significant growth through 2029, driven by advancements in various test types: ๐๐ซ๐๐ ๐ง๐๐ง๐๐ฒ & ๐ ๐๐ซ๐ญ๐ข๐ฅ๐ข๐ญ๐ฒ ๐๐๐ฌ๐ญ๐ฌ: The rising demand for rapid, self-contained tests is propelling market growth, particularly in North America, Europe, and Asia Pacific. ๐๐ข๐จ๐๐ก๐๐ฆ๐ข๐๐๐ฅ ๐๐๐ฌ๐ญ๐ฌ: With increasing cases of UTIs and kidney diseases, the market for biochemical tests, especially in laboratory settings, is expanding globally. ๐๐จ๐ข๐ง๐ญ-๐จ๐-๐๐๐ซ๐ (๐๐จ๐) ๐๐๐ฌ๐ญ๐ฌ: The convenience of PoC testing is driving this segmentโs growth, with substantial market activity in major regions. ๐๐๐๐ข๐ฆ๐๐ง๐ญ ๐๐ซ๐ข๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ: The adoption of automated analyzers is fueling growth, especially in key regions like North America and Europe. As these trends unfold, the urinalysis market is poised for robust expansion, meeting growing healthcare needs across the globe. ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐๐ญ๐ฎ๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐ Siemens Healthineers Roche Cardinal Health Danaher Corporation Abbott Sysmex Corporation Thermo Fisher Scientific QuidelOrtho BD Bio-Rad Laboratories EKF DIAGNOSTICS HOLDINGS PLC ARKRAY,Inc. ACON Laboratories 77 Elektronika Kft. URIT Medical Shenzhen Mindray Bio-Medical Electronics Co., Ltd. DIRUI Industrial Co., Ltd. Biobase Group Erba Mannheim Alphatec Scientific Teco Diagnostics Analyticon Biotechnologies GmbH BIOWAY BIOLOGICAL TECHNOLOGY CO.,LTD High Technology, Inc. Agappe Diagnostics Ltd Toyobo U.S.A., Inc. Dialab GmbH Quantimetrix Biocare Medical RANDOX LABORATORIES LIMITED CONTEC MEDICAL SYSTEMS CO., LTD. Biopanda Reagents #Urinalysis #Healthcare #Diagnostics #MedicalTesting #MarketTrends #HealthcareInnovation
About us
Your source for the latest market research, industry trends, and data-driven insights. Stay ahead of the curve with our analysis of global markets.
- Industry
- Internet News
- Company size
- 1 employee
- Headquarters
- Lewes, Delaware
- Type
- Partnership
Locations
-
Primary
16192 Coastal Hwy
Lewes, Delaware 19958, US
Updates
-
Anesthesia Equipment Market Worth to reach $11.0 billion by 2028 ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ:https://lnkd.in/ehxR8i4z The global anesthesia equipment market in terms of revenue was estimated to be worth $8.0 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at a CAGR of 6.7% from 2023 to 2028. ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐๐ญ๐ฎ๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐ GE Healthcare (US), Dragerwerk Ag & Co. KGAA (Germany), Koninklijke Philips N.V. (Netherlands), Ambu AS (Denmark), Medline Industries Inc. (US). ย ๐๐ญ๐ก๐๐ซ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ญ๐ก๐๐ญ ๐๐ซ๐ ๐จ๐ฉ๐๐ซ๐๐ญ๐ข๐ง๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ ๐ฅ๐จ๐๐๐ฅ๐ฅ๐ฒ Draegerwerk AG & Co KGaA Mindray Animal Medical North America Becton, Dickinson and Company Philips Smiths Medical Ambu A/S Fisher & Paykel Healthcare Teleflex Getinge BKK B. Braun Melsungen AG OSI Systems Masimo Nihon Kohden America InfuSystem Holdings Shenzhen Comen-Latin America Medical Instruments heyer medical AG Spacelabs Healthcare Penlon Ltd Fukuda Denshi Mindray India ORICARE Inc. NARANG MEDICAL LIMITED KARL STORZ HEINE Optotechnik Lumenis Teleflex Medical OEM SCHILLER AG ulrich medical Allied Healthcare Products, Inc. Henry Schein Medical NL 3M India Healthcare Zimmer Biomet Drive DeVilbiss Healthcare Hamilton Medical PARKER MEDICAL, INC. Intersurgical Beijing Aeonmed Co., Ltd. Ambulance Victoria (Shenzhen) Tech MINDRAY MEDICAL MรXICO, S. DE R.L. DE C.V. RWD Life Science
-
๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ฎ๐ฉ๐ฉ๐ฅ๐ฒ ๐๐ก๐๐ข๐ง ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญย ๐๐จ๐ซ๐ญ๐กย $3.3 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ:https://lnkd.in/d4MWCWKA The size of global healthcare supply chain management market in terms of revenue was estimated to be worth $2.2 billion in 2020 and is poised to reach $3.3 billion by 2025, growing at a CAGR of 7.9% from 2020 to 2025. ๐๐ฅ๐จ๐๐๐ฅ ๐๐ซ๐๐ง๐๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ฎ๐ฉ๐ฉ๐ฅ๐ฒ ๐๐ก๐๐ข๐ง ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐๐: Regulatory requirements, hospital consolidation, and rising disease prevalence are key factors driving SCM market growth. Canada: Strategic implementations are improving healthcare supply chain management across the country. ๐๐๐ซ๐ฆ๐๐ง๐ฒ: A growing focus on cloud computing and big data is unlocking market potential. ๐๐: Government support for Healthcare IT adoption is fostering market expansion. ๐ ๐ซ๐๐ง๐๐: Strong infrastructure and high healthcare expenditure present new growth opportunities. ๐๐ญ๐๐ฅ๐ฒ: Post-COVID shortages in staff and equipment highlight the need for SCM solutions. ๐๐ฉ๐๐ข๐ง: An aging population and COVID-19 impacts are driving market growth. ๐๐๐ฉ๐๐ง: Collaborative efforts for asset tracking indicate robust growth. ๐๐ก๐ข๐ง๐: Favorable regulations and the ongoing impact of COVID-19 are enhancing SCM practices. ๐๐ง๐๐ข๐: A growing healthcare industry and increasing elderly population ensure continued demand for SCM solutions. ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐๐ญ๐ฎ๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐ Oracle SAP Infor McKesson Tecsys Inc. GHX Cardinal Health Determine, a Corcentric Company Epicor Coupa Supply Chain Solutions, powered by LLamasoft Manhattan Associates Blue Yonder Cerner Corporation Jump Technologies, Inc. LogiTag Systems Harris Affinity Premier Inc. Accurate Info Soft Pvt Ltd HYBRENT TECHNOLOGIES PRIVATE LIMITED Arvato Systems #Healthcare #SupplyChainManagement #GlobalHealth #SCM #HealthcareInnovation #MarketTrends
-
AI in Drug Discovery Marketย Worthย $4.9 billion by 2028 ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ:https://lnkd.in/e76PtVpb The size of global AI in drug discovery market in terms of revenue was estimated to be worth $0.9 billion in 2023 and is poised to reach $4.9 billion by 2028, growing at a CAGR of 40.2% from 2023 to 2028 AI is transforming drug discovery by cutting costs and development time. The market is set to grow significantly by 2028, driven by key sectors: Pharmaceutical & Biotechnology Companies: AI is streamlining R&D, with global markets expanding rapidly. Contract Research Organizations (CROs): As outsourcing trends rise, CROs are using AI to enhance collaboration and innovation. Research Centers & Institutes: This segment is expected to see the highest growth, driven by AI-driven breakthroughs and collaborations. ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐๐ญ๐ฎ๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐ Exscientia Google BenevolentAI Recursion Insilico Medicine Schrรถdinger Microsoft Atomwise Illumina NuMedii XtalPi Inc. iktos Deep Genomics Verge Genomics BenchSci insitro Valo Health BPGbio, Inc. Predictive Oncology Labcorp IQVIA. IGE/Affinity Media (acq. Tencent Holdings Ltd.) Celsius Therapeutics CytoReason Owkin Cloud Pharmaceuticals, Inc. Evaxion Biotech A/S Standigm BioAge Labs Envisagenics ARIAD Pharmaceuticals, Inc.
-
CRISPR Marketย Worthย $7.1 Billion by 2028 ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ:https://lnkd.in/dfGbi8ep The global CRISPR market in terms of revenue was estimated to be worth $3.4 billion in 2023 and is poised to reach $7.1 billion by 2028, growing at a CAGR of 15.6% from 2023 to 2028. The CRISPR technology market is witnessing rapid expansion across various sectors, driven by innovative applications: ๐ฌ Drug Discovery & Development: Growth Drivers: Genome editing advancements are significantly enhancing drug discovery and development processes. Regional Insights: North America and Europe are leading, with strong growth expected in Asia Pacific and Latin America. ๐พ Agriculture: Growth Drivers: There's a growing demand for CRISPR in agriculture, particularly in enhancing crop traits to improve yield and resilience. Regional Insights: North America and Europe remain key markets, while Asia Pacific and Latin America show increasing adoption. ๐ Other Applications: Growth Drivers: CRISPR's versatility is opening up new opportunities across diverse fields. Regional Insights: Expansion is notable across all regions, with significant growth potential in emerging markets. CRISPR technology is poised to revolutionize industries, from pharmaceuticals to agriculture, with robust growth anticipated worldwide. ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐๐ญ๐ฎ๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐ Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (China), CRISPR Therapeutics AG (Switzerland), Editas Medicine (US), Intellia Therapeutics, Inc. (US), Beam Therapeutics Inc. (US), Caribou Biosciences, Inc. (US),ย Lonza Group, Ltd. (Switzerland), Danaher Corporation (US), PerkinElmer, Inc. (US),etc. ๐๐ญ๐ก๐๐ซ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐ฉ๐๐ซ๐๐ญ๐ข๐ง๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฅ๐จ๐๐๐ฅ๐ฅ๐ฒ Caszyme Cellectis Cellinfinity Bio Celularity Inc. Century Therapeutics, Inc Chroma Medicine Cimeio Therapeutics Clade Therapeutics Cognigenics CorriXR Therapeutics CRISPR QC CRISPR Therapeutics CyGenica Cytovia Therapeutics Defence Therapeutics Demeetra EdiGene Inc. Editas Medicine Edity Therapeutics eGenesis, Inc. ElevateBio Eli Lilly and Company Eligo Bioscience Emendo Biotherapeutics Emerzene Inc Ensoma Epic Bio ERS Genomics Excision BioTherapeutics Fate Therapeutics Inc. Feldan Therapeutics Gamida Cell Ltd.
-
Plasma Fractionation Marketย Size to Hit US$ย 40.4 Billion by 2028 ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ:https://lnkd.in/dAHUCfPX The global plasma fractionation market in terms of revenue was estimated to be worth $29.0 billion in 2023 and is poised to reach $40.4 billion by 2028, growing at a CAGR of 6.9% from 2023 to 2028. ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐๐ญ๐ฎ๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐ CSL TakedaPharmaceutical Nordics AB Grifols Octapharma Kedrion Biopharma LFB ADMA Biologics, Inc. Sanquin China Biologic Products Holdings Inc Gc Pharma Remedies P. Limited Hualan Biological Engineering Inc. Japan Blood Products Organization Emergent BioSolutions Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd KAMADA Centurion Pharma Prothya Biosolutions PlasmaGen BioSciences (P) Ltd Virchow Biotech Fusion Healthcare Staffing HEMARUS LLC
-
PFAS Testing Marketย Size to Hit US$ย 217 million by 2028 ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ:https://lnkd.in/dJnbaYeC The global PFAS testing market in terms of revenue was estimated to be worth $110 million in 2023 and is poised to reach $217 million by 2028, growing at a CAGR of 14.4% from 2023 to 2028. ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐๐ญ๐ฎ๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐ Agilent Technologies Merck Waters Corporation LGC Biotage AccuStandard PerkinElmer Thermo Fisher Scientific Phenomenex MACHEREY-NAGEL SHIMADZU CORPORATION Wellington Laboratories Inc. Cambridge Isotope Laboratories, Inc Chiron AS Restek Corporation SCIEX LCTech GmbH Absolute Standards Inc Cytiva Avantor Pall Corporation
-
Clinical Trials Marketย Size to Hit US$ย 73.2 Billion by 2028 ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ:https://lnkd.in/dHR9QaiK The global clinical trials market in terms of revenue was estimated to be worth $48.2 billion in 2023 and is poised to reach $73.2 billion by 2028, growing at a CAGR of 8.7% from 2023 to 2028. ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐๐ญ๐ฎ๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐ Thermo Fisher Scientific IQVIA ICON plc Laboratory Corporation of America Holdings Syneos Health WuXi AppTec Charles River Laboratories Fortrea Medpace Frontage Laboratories, Inc ACM Global Laboratories Advanced Clinical PSI CRO AG Bioagile Therapeutics Pvt Ltd CTI Clinical Trial and Consulting Services Worldwide Clinical Trials Pepgra Clinical Research Organization (CRO) for Medicines and Healthcare products CTI Clinical Trial and Consulting Services Dove Quality Solutions Firma Clinical Research Celerion Novotech Linical
-
Remote Patient Monitoring Marketย Size to Hit US$ย 207.5 Billion by 2028 ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ:https://lnkd.in/eGYK74zs The size of global remote patient monitoring market in terms of revenue was estimated to be worth $71.9 billion in 2023 and is poised to reach $207.5 billion by 2028, growing at a CAGR of 23.6% from 2023 to 2028 ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐๐ญ๐ฎ๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐ Philips Medtronic GE HealthCare Cerner Corporation Siemens Healthineers OMRON Healthcare, Inc. Boston Scientific Abbott Vivify Healthยฎ Alten Calsoft Labs Preventice Solutions Biobeat VitalConnect Welch Allyn Teladoc Health Dexcom iRhythm Technologies, Inc. HealthBeatsยฎ STARLING MEDICAL PRACTICE, LLC AliveCor Aktiia TytoCare
-
Medical aesthetics market is set to hit USD 25.9 billion by 2028 from USD 15.4 billion in 2023, increasing at a CAGR of around 11.0% during the forecast period. ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ:https://lnkd.in/e2-GGCfY ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐๐ญ๐ฎ๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐ AbbVie Galderma Johnson & Johnson Bausch Health Companies Inc. Cutera, Inc. El.En. S.p.A. InMode Lumenis Fotona USA Alma Lasers Cynosure, LLC. Merz Pharma GmbH & Co KGaA Reinheim Candela Medical Venus Concept Israel Aerolase Sciton LUTRONIC RECOSMO INC SharpLight Technologies ANIKA THERAPEUTICS S.R.L. Medytox POLYTECH Health & Aesthetics Asclepion Laser Technologies GmbH Apyx Medical GC Aesthetics Astanza Laser Huadong Medicine Co., Ltd. Chinese Patent Medicine Branch Revance